Low Dose Regimens of BNT162b2 mRNA Vaccine Exceed SARS-Cov-2 Correlate of Protection Estimates for Symptomatic Infection, in those 19-55 Years of Age

Graham Jurgens
doi: https://doi.org/10.1101/2021.03.06.21253058

Data Availability

All data generated or analysed during this study are included in this published article (and its supplementary information files)

Back to top
Posted March 11, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Low Dose Regimens of BNT162b2 mRNA Vaccine Exceed SARS-Cov-2 Correlate of Protection Estimates for Symptomatic Infection, in those 19-55 Years of Age
Graham Jurgens
medRxiv 2021.03.06.21253058; doi: https://doi.org/10.1101/2021.03.06.21253058
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area